Real-life treatment and outcome data for patients with advanced NSCLC receiving treatments containing bevacizumab – data from the clinical registry on lung cancer (TLK). 6. Juni 2014 Steffens, C.-C., Tessen, H.W., Losem, C., Münz, M., Jänicke, M., Spring, L., Marschner, N., 2014. Oncol Res Treat 37 (suppl 5)(P217), 64. doi:10.1159/000368945 Abstract Download Effectiveness of bevacizumab beyond progression in patients with metastatic colorectal cancer – data from the clinical TKK registry. Schnell, R., Musch, R., Broszeit-Luft, S., Harde, J., Kopfmann, S., Jänicke, M., Marschner, N., 2014. Oncol Res Treat 37(Suppl.5)(V332), 101. doi:10.1159/000368945… Weiterlesen Effectiveness of treatments for tumor-(therapy-) associated anemia in routine practice – data from the clinical tumor anemia registry (TAR). Steinmetz, T., Köhler, A., Groschek, M., Koenigsmann, M., Vogt, M., Frank, M., Jänicke, M., 2014. Oncol ResTreat 37 (suppl 5)(P534), 172. doi:10.1159/000368945… Weiterlesen